港股异动 | 药师帮(09885)早盘涨超4% 中期股东应占溢利同比增长258% 数字化驱动韧性增长

智通财经

Aug 22, 2025

智通财经APP获悉，药师帮(09885)早盘涨超4%，截至发稿，涨4.19%，报10.63港元，成交额1080.58万港元。

消息面上，8月20日，药师帮发布2025半年度报告，今年上半年公司实现营业收入98.43亿元，同比增长11.7%；毛利率由10%显著提升至11.2%；归母净利润7811万元，同比增长超3倍以上；经营性现金流持续净流入达2.57亿元，现金及等价物35.51亿元。在今年医药市场普遍承压的背景下，公司维持收入双位数增长，净利倍数级增长，盈利能力显著提升，现金流健康度持续良好。

智通财经APP在《药师帮（09885）上半年业绩高增长，净利达上年同期3倍以上》中指出，今年上半年，药师帮凭借着“平台+自营”的双轮驱动模式保持稳健发展，不断夯实数字化底座，重点推进自有品牌扩张、供应链效能提升、基层医疗布局等三大战略，驱动盈利结构持续优化。

自有品牌业务的持续扩张，进一步提升了公司的供给能力及运营能力，实现高毛利业务的持续增长，不断提升公司的毛利水平。报告显示，自有品牌交易规模达人民币8.52亿元，同比增长约473.4%。其中，战略单品藿香正气口服液基层医疗机构客户销售贡献占比达40%；第二个大单品乐药师肠炎宁口服液，两个月内覆盖了超过3万家的单体药店和基层医疗机构。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2561644519"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561644519\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561644519?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-08-22 09:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561644519","market":"hk","top_or_hot":-1,"title":"港股异动 | 药师帮(09885)早盘涨超4% 中期股东应占溢利同比增长258% 数字化驱动韧性增长","media":"智通财经","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/09885\">药师帮</a>(09885)早盘涨超4%，截至发稿，涨4.19%，报10.63港元，成交额1080.58万港元。</p><p>消息面上，8月20日，药师帮发布2025半年度报告，今年上半年公司实现营业收入98.43亿元，同比增长11.7%；毛利率由10%显著提升至11.2%；归母净利润7811万元，同比增长超3倍以上；经营性现金流持续净流入达2.57亿元，现金及等价物35.51亿元。在今年医药市场普遍承压的背景下，公司维持收入双位数增长，净利倍数级增长，盈利能力显著提升，现金流健康度持续良好。</p><p>智通财经APP在《药师帮（09885）上半年业绩高增长，净利达上年同期3倍以上》中指出，今年上半年，药师帮凭借着“平台+自营”的双轮驱动模式保持稳健发展，不断夯实数字化底座，重点推进自有品牌扩张、供应链效能提升、基层医疗布局等三大战略，驱动盈利结构持续优化。</p><p>自有品牌业务的持续扩张，进一步提升了公司的供给能力及运营能力，实现高毛利业务的持续增长，不断提升公司的毛利水平。报告显示，自有品牌交易规模达人民币8.52亿元，同比增长约473.4%。其中，战略单品藿香正气口服液基层医疗机构客户销售贡献占比达40%；第二个大单品乐药师肠炎宁口服液，两个月内覆盖了超过3万家的单体药店和基层医疗机构。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 药师帮(09885)早盘涨超4% 中期股东应占溢利同比增长258% 数字化驱动韧性增长</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 药师帮(09885)早盘涨超4% 中期股东应占溢利同比增长258% 数字化驱动韧性增长\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-22 09:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1333244.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，药师帮(09885)早盘涨超4%，截至发稿，涨4.19%，报10.63港元，成交额1080.58万港元。消息面上，8月20日，药师帮发布2025半年度报告，今年上半年公司实现营业收入98.43亿元，同比增长11.7%；毛利率由10%显著提升至11.2%；归母净利润7811万元，同比增长超3倍以上；经营性现金流持续净流入达2.57亿元，现金及等价物35.51亿元。在今年医药市场...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1333244.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09885","symbol_name":"药师帮","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1333244.html","article_id":"2561644519","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561644519","pubTimestamp":1755827074,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，药师帮早盘涨超4%，截至发稿，涨4.19%，报10.63港元，成交额1080.58万港元。消息面上，8月20日，药师帮发布2025半年度报告，今年上半年公司实现营业收入98.43亿元，同比增长11.7%；毛利率由10%显著提升至11.2%；归母净利润7811万元，同比增长超3倍以上；经营性现金流持续净流入达2.57亿元，现金及等价物35.51亿元。报告显示，自有品牌交易规模达人民币8.52亿元，同比增长约473.4%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"09885":"药师帮","BK1197":"保健护理产品经销商"},"translate_title":"Changes in Hong Kong stocks | Yaoshibang (09885) rose more than 4% in early trading. Interim profit attributable to shareholders increased by 258% year-on-year. Digitalization drives resilient growth","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09885":1},"content_text":"智通财经APP获悉，药师帮(09885)早盘涨超4%，截至发稿，涨4.19%，报10.63港元，成交额1080.58万港元。消息面上，8月20日，药师帮发布2025半年度报告，今年上半年公司实现营业收入98.43亿元，同比增长11.7%；毛利率由10%显著提升至11.2%；归母净利润7811万元，同比增长超3倍以上；经营性现金流持续净流入达2.57亿元，现金及等价物35.51亿元。在今年医药市场普遍承压的背景下，公司维持收入双位数增长，净利倍数级增长，盈利能力显著提升，现金流健康度持续良好。智通财经APP在《药师帮（09885）上半年业绩高增长，净利达上年同期3倍以上》中指出，今年上半年，药师帮凭借着“平台+自营”的双轮驱动模式保持稳健发展，不断夯实数字化底座，重点推进自有品牌扩张、供应链效能提升、基层医疗布局等三大战略，驱动盈利结构持续优化。自有品牌业务的持续扩张，进一步提升了公司的供给能力及运营能力，实现高毛利业务的持续增长，不断提升公司的毛利水平。报告显示，自有品牌交易规模达人民币8.52亿元，同比增长约473.4%。其中，战略单品藿香正气口服液基层医疗机构客户销售贡献占比达40%；第二个大单品乐药师肠炎宁口服液，两个月内覆盖了超过3万家的单体药店和基层医疗机构。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}